Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors (HSRC)

September 5, 2025 updated by: Texas A&M University
Healthy School Recognized Campus is a Texas A&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to improve the delivery of these programs and optimize the effect they have on youth's cardiovascular risk factors.

Study Overview

Detailed Description

The investigators will conduct a group randomized factorial trial using the Multiphase Optimization STrategy (MOST) framework to evaluate the impact (i.e., implementation and effectiveness) of three implementation strategies on program implementation and youth's cardiovascular disease risk. HSRC is a Texas A&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs.

Elementary schools in North and East Texas (n=16) of similar socio-economic status will be randomized at baseline to receive either 3, 2, 1, or no strategies to support HSRC program implementation. All schools will participate in HSRC during the full school year.

The investigators hypothesize that one strategy will result in significantly greater HSRC implementation and effectiveness than the other strategies tested.

Study Type

Interventional

Enrollment (Actual)

159

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75252
        • Texas A&M AgriLife Dallas Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

School Inclusion Criteria:

  • located in North and East Texas
  • Public elementary school

Student Inclusion Criteria"

  • at least 10 years old by September 1, 2023 (2024 for the 2024-2025 school year)
  • enrolled in the 5th or 6th grade
  • able to read, speak, and write in English

Exclusion Criteria:

  • any motor or cognitive impairments or other health conditions that would prevent them from completing a physical assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mentoring Program
Participants in this group will receive the Mentoring Program strategy in addition to Healthy School Recognized Campus.
Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
Experimental: Enhanced Resources
Participants in this group will receive the Enhanced Resources strategy in addition to Healthy School Recognized Campus.
Schools in this group will receive extra resources such as program incentives to aid in program implementation.
Experimental: Enhanced Engagement
Participants in this group will receive the Enhanced Engagement strategy in addition to Healthy School Recognized Campus.
Schools in this group will participate in program contests to aid program implementation.
No Intervention: No Intervention
All schools will participate in the HSRC initiative. The requirements for the initiative are to complete a school-wide walking program, 1 youth, and 1 adult program from a list of available programs that make up the initiative.
Experimental: Mentoring + Enhanced Resources
Participants in this group will receive the Mentoring Program and Enhanced Resources strategies in addition to Healthy School Recognized Campus.
Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
Schools in this group will receive extra resources such as program incentives to aid in program implementation.
Experimental: Mentoring + Enhanced Engagement
Participants in this group will receive the Mentoring Program and Enhanced Engagement strategies in addition to Healthy School Recognized Campus.
Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
Schools in this group will participate in program contests to aid program implementation.
Experimental: Enhanced Resources + Enhanced Engagement
Participants in this group will receive the Enhanced Resources and Enhanced Engagement strategies in addition to Healthy School Recognized Campus.
Schools in this group will receive extra resources such as program incentives to aid in program implementation.
Schools in this group will participate in program contests to aid program implementation.
Experimental: Mentoring + Enhanced Resources + Enhanced Engagement
Participants in this group will receive the Mentoring Program, Enhanced Resources, and Enhanced Engagement strategies in addition to Healthy School Recognized Campus.
Schools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
Schools in this group will receive extra resources such as program incentives to aid in program implementation.
Schools in this group will participate in program contests to aid program implementation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence or absence of metabolic syndrome (MetS)
Time Frame: Baseline, 9 months (immediate post intervention)

MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels.

MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors)

Measures to determine MetS risk factors:

  1. Abdominal obesity: waist circumference >90th percentile for child's sex and age
  2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg)
  3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes
  4. Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
  5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L
Baseline, 9 months (immediate post intervention)
Change in the number of MetS risk factors
Time Frame: Baseline, 9 months (immediate post intervention)

Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors)

Measures to determine MetS risk factors:

  1. Abdominal obesity: waist circumference >90th percentile for child's sex and age
  2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg)
  3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes
  4. Low HDL cholesterol: HDL cholesterol <1.03 mmol/L
  5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L
Baseline, 9 months (immediate post intervention)
Number of programs schools delivered (in addition to Walk Across Texas)
Time Frame: Baseline, 9 months (immediate post intervention)
Baseline, 9 months (immediate post intervention)
Number of sessions delivered for each program
Time Frame: Baseline, 9 months (immediate post intervention)
Baseline, 9 months (immediate post intervention)
Length of the sessions delivered
Time Frame: Baseline, 9 months (immediate post intervention)
Baseline, 9 months (immediate post intervention)
Individual-level attendance data for programs delivered
Time Frame: Baseline, 9 months (immediate post intervention)
Baseline, 9 months (immediate post intervention)
Body mass index (BMI)
Time Frame: Baseline, 9 months (immediate post intervention)
Weight will be measured with a scale (in pounds), and height will be measured using a stadiometer (in inches). Weight and height will be combined to report BMI as follows, BMI = (weight (lb)/height (inches)2) x 703.
Baseline, 9 months (immediate post intervention)
Concentration of subdermal carotenoids
Time Frame: Baseline, 9 months (immediate post intervention)
The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy.
Baseline, 9 months (immediate post intervention)
Physical fitness capacity estimation
Time Frame: Baseline, 9 months (immediate post intervention)
Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness.
Baseline, 9 months (immediate post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure level
Time Frame: Baseline, 9 months (immediate post intervention)
Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer.
Baseline, 9 months (immediate post intervention)
Concentration of blood glucose
Time Frame: Baseline, 9 months (immediate post intervention)
Glucose will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast.
Baseline, 9 months (immediate post intervention)
Waist circumference
Time Frame: Baseline, 9 months (immediate post intervention)
Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure.
Baseline, 9 months (immediate post intervention)
Concentration of HDL cholesterol
Time Frame: Baseline, 9 months (immediate post intervention)
HDL-C will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast.
Baseline, 9 months (immediate post intervention)
Concentration of serum triglycerides
Time Frame: Baseline, 9 months (immediate post intervention)
Triglycerides will be measured using a portable CardioChek Plus analyzer to assess a single capillary blood sample following an overnight fast.
Baseline, 9 months (immediate post intervention)
Height
Time Frame: Baseline, 9 months (immediate post intervention)
Height will be measured using a stadiometer in inches.
Baseline, 9 months (immediate post intervention)
Weight
Time Frame: Baseline, 9 months (immediate post intervention)
Weight will be measured with a scale in pounds.
Baseline, 9 months (immediate post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jacob Szeszulski, PhD, Texas A&M AgriLife

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 13, 2023

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

July 24, 2023

First Submitted That Met QC Criteria

August 2, 2023

First Posted (Actual)

August 7, 2023

Study Record Updates

Last Update Posted (Estimated)

September 12, 2025

Last Update Submitted That Met QC Criteria

September 5, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AHA HSRC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Mentoring Program

Subscribe